In a groundbreaking story MindMed (MNMD.Q) announced today has been granted approval by the Swiss Ethics Committee to evaluate the acute effects of different doses of mescaline and the…
mmed.q
Street cred MindMed (MMED.NEO) announced last fall it was applying to be listed on the Nasdaq Exchange. MindMed would be the first Canadian psychedelics company listed on a major…